Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice

World Journal of Gastroenterology

Volumn 14, Issue 27, 2008, Pages 4377-4382

  Jia, Lin ^a   Shang, Yuan Yuan ^a   Li, Yu Yuan ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Body weight; Ethology; Fluoxetine; Locomotor activity; Mirtazapine; Nude mice; Pancreatic carcinoma

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; MIRTAZAPINE; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; DRUG DERIVATIVE; MIANSERIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; ETHOLOGY; FEMALE; FOOD INTAKE; HUMAN; HUMAN CELL; INGESTION; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OPEN FIELD TEST; PANCREAS CARCINOMA; TUMOR XENOGRAFT; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BODY WEIGHT; CARCINOMA; CELL LINE, TUMOR; FEMALE; FLUOXETINE; MALE; MIANSERIN; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS;

EID: 55949113359     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4377     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66
2. Li D, Xie K, Wolff R, Abbruzzese IL. Pancreatic cancer. Lancet 2004; 363: 1049-1057
3. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 1995; 52: 89-99
4. Carney CP, Jones L, Woolson RF, Noyes R Jr, Doebbeling BN. Relationship between depression and pancreatic cancer in the general population. Psychosom Med 2003; 65: 884-888
5. Fazal S, Saif MW. Supportive and palliative care of pancreatic cancer. JOP 2007; 8: 240-253
6. Okano Y, Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, Kazuma K, Akechi T, Uchitomi Y. Mental adjustment to first recurrence and correlated factors in patients with breast cancer. Breast Cancer Res Treat 2001; 67: 255-262
7. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002; 53: 859-863
8. Thompson DS. Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology. Psychosomatics 2000; 41: 356-359
9. Unutzer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler E, Harpole L, Hoffing M, Della Penna RD, Noel PH, Lin EH, Arean PA, Hegel MT, Tang L, Belin TR, Oishi S, Langston C. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002; 288: 2836-2845
10. Holm KJ, Markham A. Mirtazapine: a review of its use in major depression. Drugs 1999; 57: 607-631
11. Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT, Kennett GA. Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28-days as a, result of maintained hypophagia. Psychopharmacology (Berl) 2003; 167: 274-280
12. Bechtholt AJ, Hill TE, Lucki I. Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test. Psychopharmacology (Bed) 2007; 190: 531-540
13. Jia L, Zhang MH, Yuan SZ, Huang WG. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice. Word J Gastroenterol 2005; 11: 447-450
14. Weber CC, Eckert GP, Muller WE. Effects of antidepressants on the brain/plasma distribution of corticosterone. Neuropsychopharmacology 2006; 31: 2443-2448
15. Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin Cancer Res 2003; 9: 6534-6544
16. Palumbo ML, Fosser NS, Rios H, Zorrilla Zubilete MA, Guelman LR, Cremaschi GA, Genaro AM. Loss of hippocampal neuronal nitric oxide synthase contributes to the stress-related deficit in learning and memory. J Neurochem 2007; 102: 261-274
17. Garattini S, Bizzi A, Codegoni AM, Caccia S, Mennini T. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr 1992; 55: 160S-166S
18. Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001; 7: 249-264
19. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmacher T. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 2002; 35: 220-225
20. Gerrits M, Bakker PL, Koch T, Ter Horst GJ. Stress-induced sensitization of the limbic system in ovariectomized rats is partly restored by cyclic 17beta-estradiol administration. Eur J Neurosci 2006; 23: 1747-1756
21. Heisler LK, Kanarek RB, Gerstein A. Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats. Pharmacol Siochem Behav 1997; 58: 767-773
22. Heisler LK, Kanarek RB, Homoleski B. Reduction of fat and protein intakes but not carbohydrate Intake following acute and chronic fluoxetine in female rats. Pharmacol Biochem Behav 1999; 63: 377-385
23. Foltin RW, Haney M, Comer SD, Fischman MW. Effect of fluoxetine on food intake of humans living in a residential laboratory. Appetite 1996; 27: 165-181
24. Ward AS, Comer SD, Haney M, Fischman MW, Foltin RW. Fluoxetine-maintained obese humans: effect on food intake and body weight. Physiol Behav 1999; 66: 815-821
25. Huang YL, Yu JP, Wang GH, Chen ZH, Wang Q, Xiao L. Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum. World J Gastroenterol 2007; 13: 6060-6065
26. Reneric JP, Bouvard M, Stinus L. In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed. Eur Neuropsychopharmacol 2002; 12: 159-171
27. Bendele RA, Adams ER, Hoffman WP, Gries CL, Morton DM. Carcinogenicity studies of fluoxetine hydrocloride in rats and mice. Cancer Res 1992; 52: 6931-6935
28. Abdul M, Logothetis CJ, Hodsein NM. Growth inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J Urol 1995; 154: 247-250
29. Mattox TW. Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract 2005; 20: 400-410
30. Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage 2002; 23: 442-447